Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Testing healthy men, who have no symptoms and no family history, is controversial. Discuss your risk factors with your physician.
Prostate cancer screening tests include:
Digital rectal exam (DRE): Your doctor inserts a gloved lubricated finger inside your rectum to feel your prostate for abnormalities in texture, shape, or size.
Prostate-specific antigen (PSA) test: This is a blood test that evaluates the amount of this antigen in your bloodstream. A high PSA is not confirmation of prostate cancer. Sometimes the PSA level is elevated due to infection, inflammation, or enlargement of the prostate gland.
If a doctor or facility outside Stanford has already given you a diagnosis, we will have your results sent to our pathologists (doctors specializing in cancer diagnosis). They will review your test results and confirm or revise your diagnosis.
At Stanford, we look at you as an individual when trying to figure out the severity of your prostate cancer. If you need further testing to complete your diagnosis, your care team will work with you to determine which tests you need. Tests may include:
Prostate Imaging (Radiology) To obtain the most precise understanding of your cancer, your doctor may schedule you for different types of prostate imaging that diagnose and treat prostate cancer. If you have been screened elsewhere and received abnormal results, we may perform additional follow-up tests, if needed.
Prostate Biopsy (Pathology) If your imaging or other screening tests show that you may have prostate cancer, you will need a prostate biopsy. This test takes small samples of cells from your prostate to check for cancer.
Prostate Lab Tests (Blood Draws) Before and during treatment, your doctor will ask you to have your blood drawn and tested at a lab. Blood tests can provide a variety of information, helping to establish your diagnosis and plan your course of prostate cancer treatment.
We offer robust clinical trial programs for prostate cancer. These research studies evaluate new medical approaches, devices, drugs, and other treatments.
As a Stanford Health Care patient, you may be eligible to participate in open clinical trials. Open trials refer to studies currently recruiting participants or that may recruit participants in the near future. Closed trials are not currently enrolling, but similar studies may open in the future.
You can access Stanford’s expertise and compassionate care for any stage or type of prostate cancer at a location that is convenient for you. We always accept new patients, and we take many insurance plans, including Medicare and Medi-Cal.